Cited In for PMID: 19997607

Year	Number of Results
2009	1
2010	2
2011	2
2012	4
2015	1
2016	1
2017	4
2018	1
2020	3
2021	3
2022	2
2023	1
2024	0

1

Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease.

Sarantseva S, Timoshenko S, Bolshakova O, Karaseva E, Rodin D, Schwarzman AL, Vitek MP. Sarantseva S, et al. PLoS One. 2009 Dec 7;4(12):e8191. doi: 10.1371/journal.pone.0008191. PLoS One. 2009. PMID: 19997607 Free PMC article.

2

Towards early detection of neurodegenerative diseases: A gut feeling.

Makdissi S, Parsons BD, Di Cara F. Makdissi S, et al. Front Cell Dev Biol. 2023 Feb 7;11:1087091. doi: 10.3389/fcell.2023.1087091. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36824371 Free PMC article. Review.

3

Apolipoprotein E and Alzheimer's disease.

Troutwine BR, Hamid L, Lysaker CR, Strope TA, Wilkins HM. Troutwine BR, et al. Acta Pharm Sin B. 2022 Feb;12(2):496-510. doi: 10.1016/j.apsb.2021.10.002. Epub 2021 Oct 15. Acta Pharm Sin B. 2022. PMID: 35256931 Free PMC article. Review.

4

COG133 Attenuates the Early Brain Injury Induced by Blood-Brain Barrier Disruption in Experimental Subarachnoid Hemorrhage.

Zhang Y, Gao B, Ouyang J, Tai B, Zhou S. Zhang Y, et al. J Healthc Eng. 2022 Jan 7;2022:4404039. doi: 10.1155/2022/4404039. eCollection 2022. J Healthc Eng. 2022. PMID: 35035834 Free PMC article. Retracted.

5

Empowering Melatonin Therapeutics with Drosophila Models.

Millet-Boureima C, Ennis CC, Jamison J, McSweeney S, Park A, Gamberi C. Millet-Boureima C, et al. Diseases. 2021 Sep 26;9(4):67. doi: 10.3390/diseases9040067. Diseases. 2021. PMID: 34698120 Free PMC article. Review.

6

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank.

Vitek MP, Araujo JA, Fossel M, Greenberg BD, Howell GR, Rizzo SJS, Seyfried NT, Tenner AJ, Territo PR, Windisch M, Bain LJ, Ross A, Carrillo MC, Lamb BT, Edelmayer RM. Vitek MP, et al. Alzheimers Dement (N Y). 2021 Jan 11;6(1):e12114. doi: 10.1002/trc2.12114. eCollection 2020. Alzheimers Dement (N Y). 2021. PMID: 33457489 Free PMC article.

7

Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action.

Meloni BP, Mastaglia FL, Knuckey NW. Meloni BP, et al. Front Neurol. 2020 Feb 25;11:108. doi: 10.3389/fneur.2020.00108. eCollection 2020. Front Neurol. 2020. PMID: 32158425 Free PMC article.

8

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease.

Williams T, Borchelt DR, Chakrabarty P. Williams T, et al. Mol Neurodegener. 2020 Jan 31;15(1):8. doi: 10.1186/s13024-020-0358-9. Mol Neurodegener. 2020. PMID: 32005122 Free PMC article. Review.

9

Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans.

Jones SV, Kounatidis I. Jones SV, et al. Front Immunol. 2017 Dec 11;8:1805. doi: 10.3389/fimmu.2017.01805. eCollection 2017. Front Immunol. 2017. PMID: 29312321 Free PMC article. Review.

10

Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.

Cheng X, Zheng Y, Bu P, Qi X, Fan C, Li F, Kim DH, Cao Q. Cheng X, et al. Exp Neurol. 2018 Jan;299(Pt A):97-108. doi: 10.1016/j.expneurol.2017.10.014. Epub 2017 Oct 19. Exp Neurol. 2018. PMID: 29056364 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year